Research Report on Rat Model Market Globally strategic overview july 2019 | Page 2

On the basis of therapeutic area, the market is segmented into toxicology, oncology,
immunology & inflammation, diabetes, neurology, and other therapeutic areas (rare diseases,
cardiovascular diseases, metabolic diseases, hematopoiesis, and renal disorders). In 2016, the
toxicology segment is expected to command the largest share of the global rat model market.
On the basis of service, the market is segmented into breeding, quarantine, rederivation,
cryopreservation, genetic testing, model-in-licensing, and other services (surgical services, line
rescue services, and in vivo pharmacology services). In 2016, the breeding services segment is
expected to command the largest share of the global rat model market.
On the basis of end user, the rat model market is segmented into pharmaceutical &
biotechnology companies, academic & research institutions, and contract research
organizations (CROs). In 2016, the pharmaceutical & biotechnology companies segment is
expected to command the largest share of the global rat model market.
On the basis of care product, the market is segmented into bedding, cages, feed, and other
products (gnotobiotic equipment, water systems, water purification systems, and sound
absorption panels). In 2016, the cages segment is expected to command the largest share of
the market.
Charles River Laboratories International, Inc. (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo
(U.K.), Laboratory Corporation of America Holdings (U.S.), Biomere (U.S.), Janvier Labs (France),
genOway SA (France), and Horizon Discovery Group plc (U.K.) are some of the key players in the
rat model market worldwide.
Know more about key industry players: https://www.marketsandmarkets.com/ResearchInsight/rat-
model-market.asp
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies
as clients. Almost 75,000 top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth
markets following the "Growth Engagement Model – GEM". The GEM aims at proactive
2